Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317690 · ClinicalTrials.gov registry record
Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 539
- Enrollment target
NCT04317690: Completed study, sponsored by Massachusetts General Hospital.
NCT04317690 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 539 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04317690 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 539 participants
- Enrollment target
Study Summary
The purpose of this study is to survey a sample of adults who have recently made a decision about treatment of high cholesterol or high blood pressure or a decision about screening for colorectal cancer, breast cancer, or prostate cancer. The main goal is to gather evidence of the validity and reliability of the Shared Decision Making Process scale. Secondary goal is to gather evidence on the quality of decisions for these common medical situations.
Primary Outcome
The Shared Decision Making Process is a short patient-reported survey that measures the amount of shared decision making that occurs in an interaction. Scores range from 0-4 where higher values indicate a better shared decision making process occurred.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 539 participants |
| Start Date | 2020-03-17 |
| Est. Completion | 2020-06-29 |
What the finished NCT04317690 record still lists
NCT04317690 is an observational study that tracks outcomes without assigning an intervention. The registered 539 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04317690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04317690 about?
NCT04317690 is a clinical study titled "Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey". The purpose of this study is to survey a sample of adults who have recently made a decision about treatment of high cholesterol or high blood pressure or a decision about screening for colorectal cancer, breast cancer, or prostate cancer. The main goal is to gather evidence of the validity and relia...
What is the current status of trial NCT04317690?
This trial is currently completed. The enrollment target is 539 participants. The study started on 2020-03-17. Estimated completion is 2020-06-29.
Who is sponsoring clinical trial NCT04317690?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05429892 · 540 participants · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI